Amendments Concerning Controlled Substances

Summary#

This is a proposed set of amendments from the Department of Health to several federal rules that deal with drugs and controlled substances. The changes mostly update definitions and references so they point to the Controlled Substances Regulations, and they adjust rules on licensing fees, labelling, background checks and precursor controls. This is a proposal published on June 1, 2024; people can comment for 60 days.

What it does#

• Replaces several local definitions so they instead refer to the Controlled Substances Regulations (for example, definitions of “narcotic”, “controlled drug” and “dealer’s licence”).
• Changes fee rules:
  • Clarifies that some dealer-licence fees relate only to licences for narcotics or controlled drugs.
  • Says the fee must be paid when the application or renewal is submitted.
  • Exempts drugs for “veterinary use only” from certain fee rules.
• Updates drug labelling and pharmacy/wholesale rules in the Food and Drug Regulations, including:
  • Labelling symbols (for example, requiring the “N” symbol for narcotics).
  • Which drugs are treated as prescription-only for various rules.
  • Definitions used for wholesalers and licensing requirements.
• Changes the Medical Devices Regulations and other rules to refer to the Controlled Substances Regulations and to exclude certain drugs (including some cannabis products and animal-only drugs) from parts of those regulations.
• Adjusts the Precursor Control Regulations to allow certain activities if the person holds a dealer’s licence under the Controlled Substances Regulations or an exemption under the Controlled Drugs and Substances Act.
• Changes how criminal-record checks are documented:
  • Requires a document from a Canadian police force or an RCMP-accredited company showing the person’s criminal record (or that they have no record) for the previous 10 years.
  • Repeals one existing subparagraph (technical change noted in the proposal).
• Timing: the proposal says the new rules would come into force on the 365th day after they are published in the Canada Gazette, Part II (if adopted).

Note: This is a proposed regulatory text (Part I). It is not law yet and may change after the comment period.

Who's affected#

• Licensed dealers of narcotics and other controlled drugs (people and companies holding or applying for a dealer’s licence).
• Pharmacies, wholesalers and drug distributors who handle prescription drugs, narcotics, controlled drugs or targeted substances.
• Drug manufacturers and importers whose licences and product labels are governed by the Food and Drug Regulations and related rules.
• Health care facilities and professionals, including nurse practitioners (the proposal updates how that term is defined in relation to controlled-substance rules).
• Veterinarians and businesses dealing only with animal-use drugs (some rules explicitly exclude veterinary-use-only drugs).
• Businesses and people who deal with chemical precursors.
• Canadian police forces and companies accredited by the Royal Canadian Mounted Police that provide criminal-record documents.

If any part of who is affected is unclear from the proposal, that is because the text focuses on legal definitions and cross-references rather than concrete lists of affected firms.

Why it matters#

• It simplifies and standardizes how many rules refer to controlled substances by pointing multiple regulations to the same source definitions. That can make compliance clearer for businesses and health providers.
• Some practical changes to watch:
  • Applicants must pay certain dealer-licence fees when they submit an application. That affects cash flow and budgeting for licence applicants.
  • Label and packaging rules are clarified for narcotics and other controlled drugs, which affects manufacturers and pharmacies.
  • Background checks will be provided as a 10-year record from police or RCMP-accredited companies, which changes how employers and licence authorities verify criminal histories.
  • The delayed start date (the 365th day after Part II publication, if adopted) would give affected parties time to prepare.
• Because this is a proposal, stakeholders can comment during the 60-day consultation window; the final text could differ from what is described here.